Showing results (2981-2990 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 2, 1998
Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinomaT Iizasa, T Fujisawa, Y Saitoh, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patientsR Ridolfi, E Flamini, A Riccobon, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2015
Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccinationDionisia Quiroga, Yasser A Aldhamen, Daniel M Appledorn, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2015
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanomaOliver Klein, Ian D Davis, Grant A McArthur, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2015
The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activityChristian Hess, Dario Neri
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Presence of normal human cell surface antigens in plasma of athymic mice bearing a human colon carcinoma and in normal human plasmaY Markson, D W Weiss, O Weiss, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Effects of the removal of adherent and phagocytic cells on the spleen cell lymphoproliferative response of tumor-bearing miceA M Hyde, R B Stagg, R McEachron, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Activation of mouse peritoneal macrophages by synthetic glyceroglycolipid liposomesM Naito, I Kudo, Y Mukai-Sato, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived miceM V Pimm, A C Perkins, N C Armitage, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2019
Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse modelYuki Kasahara, Hidekazu Shirota, Sho Umegaki, et al.
Pageof 652